Longevity Medicine, Functional Wellness & Anti-Aging Insights from HormoneSynergy®

Not all plaque is the same. Soft plaque is often invisible on standard tests and responsible for many heart attacks, while calcified plaque is easier to detect but often more stable. Understanding the difference is critical in longevity medicine.

A coronary calcium score of zero can be reassuring, but it does not rule out soft plaque, early coronary disease, or future cardiovascular risk. In longevity medicine, a zero calcium score is one data point—not the whole story.

LDL particle number (LDL-P) measures how many atherogenic particles are circulating in the blood. In longevity medicine, it helps explain cardiovascular risk that may be missed when LDL cholesterol appears normal.

The triglyceride-to-HDL ratio is one of the simplest ways to assess insulin resistance, metabolic health, and hidden cardiovascular risk. In longevity medicine, this ratio often reveals more than standard cholesterol numbers alone.

Triglycerides are more than a secondary number on a cholesterol panel, but they are not a diagnosis by themselves. Elevated levels can accompany insulin resistance, visceral adiposity, diabetes, alcohol use, certain medications, genetic disorders and other conditions. The clinical value comes from interpreting triglycerides alongside apoB, non-HDL cholesterol, glucose metabolism and the patient's broader cardiovascular risk.

Lipoprotein(a), or Lp(a), is a genetically influenced cardiovascular risk marker that can increase plaque risk even when routine cholesterol numbers look acceptable. In longevity medicine, Lp(a) helps explain why some people develop silent heart disease despite being told their labs are “normal.”

ApoB estimates the number of circulating atherogenic lipoprotein particles rather than the amount of cholesterol carried inside them. It can be particularly useful when LDL-C does not fully reflect particle burden, when triglycerides are elevated, or when cardiovascular risk remains uncertain despite treatment. The 2026 ACC/AHA dyslipidemia guideline gives ApoB a more defined role without turning it into a universal screening test or replacement for LDL-C.

Sleep quality affects insulin sensitivity, glucose regulation, appetite signaling, and metabolic recovery. Learn why poor sleep can quietly drive insulin resistance and long-term health risk in longevity medicine.

Sleep deprivation disrupts cortisol, hormone balance, metabolism, and mental health. Learn how poor sleep creates a stress-response cycle that affects recovery and long-term longevity.

Deep sleep and REM are not interchangeable. Each phase of sleep supports brain function, hormone balance, metabolic recovery, and long-term health. Learn why sleep architecture matters in longevity medicine.

Circadian rhythm regulates hormone balance, sleep cycles, metabolism, and recovery. Learn how sleep timing—not just duration—impacts cortisol, insulin sensitivity, brain function, and long-term longevity.

Sleep quality—not just sleep duration—is a foundational driver of metabolic health, brain function, hormone balance, and long-term longevity. This guide explains how sleep impacts recovery, insulin sensitivity, inflammation, and aging.